Total Payments
$388.99
2021 Payments
$26.42
Companies
10
Transactions
31
Medicare Patients
2,875
Medicare Billing
$308,139
Payment Breakdown by Category
Food & Beverage$388.99 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $388.99 | 31 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $125.73 | 14 | $0 (2018) |
| Janssen Biotech, Inc. | $85.36 | 6 | $0 (2019) |
| Valeant Pharmaceuticals North America LLC | $44.68 | 3 | $0 (2017) |
| BioFire Diagnostics, LLC | $39.86 | 1 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $24.95 | 2 | $0 (2019) |
| Ferring Pharmaceuticals Inc. | $17.37 | 1 | $0 (2019) |
| AbbVie Inc. | $13.70 | 1 | $0 (2021) |
| PFIZER INC. | $13.27 | 1 | $0 (2019) |
| Celgene Corporation | $12.72 | 1 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $11.35 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $26.42 | 2 | AbbVie Inc. ($13.70) |
| 2020 | $39.86 | 1 | BioFire Diagnostics, LLC ($39.86) |
| 2019 | $85.73 | 6 | Janssen Biotech, Inc. ($30.14) |
| 2018 | $36.81 | 3 | Janssen Biotech, Inc. ($25.70) |
| 2017 | $200.17 | 19 | Allergan Inc. ($114.62) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/23/2021 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $12.72 | General |
| Category: Neuroscience | ||||||
| 01/08/2021 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: VIROLOGY | ||||||
| 02/21/2020 | BioFire Diagnostics, LLC | BioFire FilmArray (Device) | Food and Beverage | Cash or cash equivalent | $39.86 | General |
| Category: Clinical Diagnostics | ||||||
| 10/09/2019 | Ferring Pharmaceuticals Inc. | CLENPIQ (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/23/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Entyvio (Biological) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Lower GI | ||||||
| 05/14/2019 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $10.09 | General |
| 04/06/2019 | Janssen Biotech, Inc. | SIMPONI (Biological), STELARA | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Immunology | ||||||
| 03/08/2019 | Janssen Biotech, Inc. | STELARA (Biological), SIMPONI | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Immunology | ||||||
| 01/11/2019 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/10/2018 | Allergan Inc. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $11.11 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/07/2018 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $11.79 | General |
| Category: Immunology | ||||||
| 07/13/2018 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological), STELARA | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Immunology | ||||||
| 12/08/2017 | Allergan Inc. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $3.18 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/07/2017 | Allergan Inc. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $5.65 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/17/2017 | Allergan Inc. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $7.51 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/16/2017 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $2.36 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/14/2017 | Allergan Inc. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $11.63 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/08/2017 | Valeant Pharmaceuticals North America LLC | APRISO (Drug), UCERIS | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/06/2017 | Allergan Inc. | LINZESS (Drug), VIBERZI | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/06/2017 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Immunology | ||||||
| 05/30/2017 | Valeant Pharmaceuticals North America LLC | XIFAXANIBSD (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/26/2017 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/18/2017 | Allergan Inc. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/10/2017 | Allergan Inc. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $11.10 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/01/2017 | Valeant Pharmaceuticals North America LLC | APRISO (Drug), UCERIS | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 712 | 780 | $359,178 | $75,303 |
| 2022 | 13 | 658 | 760 | $339,895 | $73,908 |
| 2021 | 13 | 733 | 845 | $320,273 | $85,051 |
| 2020 | 13 | 772 | 923 | $321,482 | $73,877 |
Total Patients
2,875
Total Services
3,308
Medicare Billing
$308,139
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 160 | 188 | $25,932 | $12,467 | 48.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 98 | 99 | $88,983 | $11,544 | 13.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 47 | 48 | $50,822 | $9,618 | 18.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 104 | 107 | $87,450 | $7,900 | 9.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 64 | 74 | $14,855 | $6,707 | 45.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 43 | 51 | $14,323 | $5,603 | 39.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 51 | 51 | $10,482 | $4,107 | 39.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 42 | 56 | $8,254 | $3,714 | 45.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 23 | 24 | $9,357 | $3,393 | 36.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $7,874 | $3,220 | 40.9% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 14 | 14 | $14,239 | $1,981 | 13.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 11 | 11 | $9,926 | $1,914 | 19.3% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 14 | 15 | $9,516 | $1,577 | 16.6% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 16 | 17 | $7,165 | $1,559 | 21.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 98 | 135 | $27,787 | $13,629 | 49.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 119 | 162 | $22,718 | $11,231 | 49.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 113 | 120 | $95,586 | $9,516 | 10.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 45 | 47 | $50,482 | $8,994 | 17.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 75 | 76 | $66,612 | $8,177 | 12.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 46 | 46 | $14,245 | $5,356 | 37.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 23 | 23 | $8,745 | $3,864 | 44.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 43 | 54 | $7,740 | $3,255 | 42.1% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 21 | 22 | $21,301 | $2,992 | 14.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 26 | 26 | $7,026 | $2,718 | 38.7% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 19 | 19 | $7,502 | $1,659 | 22.1% |
About Dr. Stephen Willis, MD
Dr. Stephen Willis, MD is a Gastroenterology healthcare provider based in Phillipsburg, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1629139076.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Willis, MD has received a total of $388.99 in payments from pharmaceutical and medical device companies, with $26.42 received in 2021. These payments were reported across 31 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($388.99).
As a Medicare-enrolled provider, Willis has provided services to 2,875 Medicare beneficiaries, totaling 3,308 services with total Medicare billing of $308,139. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Phillipsburg, NJ
- Active Since 12/12/2006
- Last Updated 10/03/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1629139076
Products in Payments
- VIBERZI (Drug) $71.08
- STELARA (Biological) $56.19
- LINZESS (Drug) $54.65
- BioFire FilmArray (Device) $39.86
- APRISO (Drug) $30.64
- CLENPIQ (Drug) $17.37
- SIMPONI (Biological) $15.26
- Entyvio (Biological) $14.86
- XIFAXANIBSD (Drug) $14.04
- SIMPONI ARIA (Biological) $13.91
- MAVYRET (Drug) $13.70
- XELJANZ (Drug) $13.27
- ZEPOSIA (Drug) $12.72
- ZEPATIER (Drug) $11.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.